Regulation of {beta}-Catenin Phosphorylation by PR55{beta} in Adenoid Cystic Carcinoma

Conclusion: Our study provides new insight into the interaction between PR55β and β-catenin and suggests that PR55β may be a target for the clinical treatment of AdCC.

Source: Cancer Genomics and Proteomics - December 23, 2017 Category: Cancer & Oncology Authors: ISHIBASHI, K., ISHII, K., SUGIYAMA, G., KAMATA, Y., SUZUKI, A., KUMAMARU, W., OHYAMA, Y., NAKANO, H., KIYOSHIMA, T., SUMIDA, T., YAMADA, T., MORI, Y. Tags: Article Source Type: research